U.S. Markets close in 2 hrs 57 mins
  • S&P 500

    4,426.42
    +25.78 (+0.59%)
     
  • Dow 30

    35,128.39
    +197.46 (+0.57%)
     
  • Nasdaq

    14,811.15
    +48.57 (+0.33%)
     
  • Russell 2000

    2,251.44
    +26.48 (+1.19%)
     
  • Crude Oil

    73.35
    +0.96 (+1.33%)
     
  • Gold

    1,834.80
    +30.20 (+1.67%)
     
  • Silver

    25.73
    +0.85 (+3.41%)
     
  • EUR/USD

    1.1888
    +0.0041 (+0.3447%)
     
  • 10-Yr Bond

    1.2610
    0.0000 (0.00%)
     
  • Vix

    17.62
    -0.69 (-3.77%)
     
  • GBP/USD

    1.3965
    +0.0056 (+0.4036%)
     
  • USD/JPY

    109.5340
    -0.3760 (-0.3421%)
     
  • BTC-USD

    39,739.43
    -329.23 (-0.82%)
     
  • CMC Crypto 200

    936.94
    +6.58 (+0.71%)
     
  • FTSE 100

    7,078.42
    +61.79 (+0.88%)
     
  • Nikkei 225

    27,782.42
    +200.76 (+0.73%)
     

Lawsuits Filed Against LX, GOCO and CACC - Jakubowitz Law Pursues Shareholders Claims

·4 min read

NEW YORK, NY / ACCESSWIRE / November 4, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Lexinfintech Holdings, Ltd. (NASDAQ:LX)

CONTACT JAKUBOWITZ ABOUT LX:
https://claimyourloss.com/securities/lexinfintech-holdings-ltd-loss-submission-form/?id=10691&from=1

This lawsuit is on behalf of shareholders who purchased or otherwise acquired: (a) Lexin American depositary shares pursuant and/or traceable to the Company's initial public offering conducted on or about December 21, 2017; or (b) Lexin securities between December 21, 2017 and August 24, 2020.

Lead Plaintiff Deadline : November 9, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) LexinFintech reported artificially low delinquency rates by giving borrowers in default new funds to make payments; (2) the Company's business model exposes shareholders to enormous losses by prioritizing Chinese lenders for off-balance sheet loans; (3) the Company exaggerated its user base; (4) the Company was facilitating direct peer to peer lending contrary to Chinese law; (5) the Company engaged in undisclosed related party transactions; (6) the Company lacked adequate internal controls; and (7) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

GoHealth, Inc. (NASDAQ:GOCO)

CONTACT JAKUBOWITZ ABOUT GOCO:
https://claimyourloss.com/securities/gohealth-inc-loss-submission-form/?id=10691&from=1

The GoHealth lawsuit is on behalf of all purchasers of GoHealth Class A common stock pursuant and/or traceable to the registration statement issued in connection with GoHealth's July 2020 initial public offering.

Lead Plaintiff Deadline : November 20, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the Medicare insurance industry was undergoing a period of elevated churn, which had begun in the first half of 2020; (ii) GoHealth suffered from a higher risk of customer churn as a result of its unique business model and limited carrier base; (iii) GoHealth suffered from degradations in customer persistency and retention as a result of elevated industry churn, vulnerabilities that arose from the Company's concentrated carrier business model, and GoHealth's efforts to expand into new geographies, develop new carrier partnerships and worsening product mix; (iv) GoHealth had entered into materially less favorable revenue sharing arrangements with its external sales agents; and (v) these adverse financial and operational trends were internally projected by GoHealth to continue and worsen following the initial public offering.

Credit Acceptance Corporation (NASDAQ:CACC)

CONTACT JAKUBOWITZ ABOUT CACC:
https://claimyourloss.com/securities/credit-acceptance-corporation-loss-submission-form/?id=10691&from=1

Class Period : November 1, 2019 - August 28, 2020

Lead Plaintiff Deadline : December 1, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the Company was topping off the pools of loans that they packaged and securitized with higher-risk loans; (ii) Credit Acceptance was making high-interest subprime auto loans to borrowers that the Company knew borrowers would be unable to repay; (iii) the borrowers were subject to hidden finance charges, resulting in loans exceeding the usury rate ceiling mandated by state law; (iv) Credit Acceptance took excessive and illegal measures to collect debt from defaulted borrowers; (v) as a result, the Company was likely to face regulatory scrutiny and possible penalties from various regulators or lawsuits; and (vi) that, as a result of the foregoing, Defendants positive statements about the Company's business, operations, and adherence to appropriate laws and regulations were materially misleading and/or lacked a reasonable basis.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law



View source version on accesswire.com:
https://www.accesswire.com/614414/Lawsuits-Filed-Against-LX-GOCO-and-CACC--Jakubowitz-Law-Pursues-Shareholders-Claims